Concepedia

Publication | Open Access

Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety

DOIFull Paper Access

41

Citations

42

References

2023

Year

Jaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, Julio C. Reina, Punnee Pitisuttithum, Àngels Ulied, Linda‐Gail Bekker, Edson Duarte Moreira, Sven‐Eric Olsson, Stan L. Block,
PEDIATRICS

Abstract

The 9vHPV vaccine demonstrated sustained immunogenicity and effectiveness through ∼10 years post 3 doses of 9vHPV vaccination of boys and girls aged 9 to 15 years.

References

YearCitations

Page 1